Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
Common Stock · CUSIP: 00973Y108
Event date: 2025-12-31
- Filing-level shares
- 3,397,779
- Percent of class
- 4.1%
- JANUS HENDERSON GROUP PLC
Shares: 3,397,779 · Class: 4.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-26-000064
- Form type
- SCHEDULE 13G/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership